Product News

Published Online: Monday, September 1, 2008
Follow Pharmacy_Times:

Amantadine Hydrochloride USP Capsules

Marketed by:

Banner Pharmacaps Inc (High Point, NC)

Compared to:

Amantadine Hydrochloride (USL Pharma)

Indication:

June 2, 2008—Banner Pharmacaps Inc announced that the FDA approved its Abbreviated New Drug Application for Amantadine Hydrochloride USP 100-mg soft gelatin capsules. Amantadine is indicated for the prophylaxis and treatment of signs and symptoms of infection in the respiratory tract caused by various strains of influenza A virus. Amantadine also is used in the treatment of Parkinson's disease and drug-induced extrapyramidal reactions.

Dosage Form:

Capsules: 100 mg

For More Information:
www.banpharm.com



Lamotrigine Tablets

Marketed by:

Teva Pharmaceuticals (North Wales, PA)

Compared to:

Lamictal Tablets (GlaxoSmithKline)

Indication:

July 22, 2008—Teva Pharmaceuticals announced the introduction and availability of Lamotrigine Tablets. Lamotrigine Tablets are indicated as adjunctive therapy for partial seizures and the generalized seizures of Lennox?Gastaut syndrome in adults and pediatric patients (=2 years of age). The tablets also are indicated for conversion to monotherapy in adults with partial seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug. Lamotrigine also is indicated for the maintenance treatment of bipolar I disorder.

Dosage Form:

Tablets: 25, 100, 150, and 200 mg

For More Information:
www.tevausa.com
888-TEVA USA (888-838-2872)



Meclizine HCl Tablets

Marketed by:

Par Pharmaceutical Companies Inc (Woodcliff Lake, NJ)

Compared to:

Antivert (Pfizer Inc)

Indication:

July 9, 2008—Par Pharmaceutical Companies Inc announced that it began shipment of 12.5- and 25-mg Meclizine HCl Tablets. Meclizine is an oral antiemetic indicated for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness. It is contraindicated in individuals who have shown a previous hypersensitivity to it. The initial dose of 25 to 50 mg Meclizine HCl should be taken 1 hour prior to travel for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

Dosage Form:

Tablets: 12.5 and 25 mg

For More Information:
www.parpharm.com



Potassium Chloride Extendedrelease Capsules

Marketed by:

Watson Pharmaceuticals Inc (Corona, CA)

Compared to:

Micro-K Extencaps USP (KV Pharmaceutical)

Indication:

June 3, 2008—Watson Pharmaceuticals announced that it received approval from the FDA for its Abbreviated New Drug Application for Potassium Chloride Extended-release Capsules USP in 8- and 10-mEq strengths. Potassium chloride is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis.

Dosage Form:

Capsules: 8 and 10 mEq

For More Information:
www.watson.com





Related Articles
No Result Found
Latest Issues
$auto_registration$